<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34787357</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties.</ArticleTitle><Pagination><StartPage>e53632</StartPage><MedlinePgn>e53632</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e53632</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.202153632</ELocationID><Abstract><AbstractText>TDP-43 is an RNA-binding protein that forms ribonucleoprotein condensates via liquid-liquid phase separation (LLPS) and regulates gene expression through specific RNA interactions. Loss of TDP-43 protein homeostasis and dysfunction are tied to neurodegenerative disorders, mainly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Alterations of TDP-43 LLPS properties may be linked to protein aggregation. However, the mechanisms regulating TDP-43 LLPS are ill-defined, particularly how TDP-43 association with specific RNA targets regulates TDP-43 condensation remains unclear. We show that RNA binding strongly promotes TDP-43 LLPS through sequence-specific interactions. RNA-driven condensation increases with the number of adjacent TDP-43-binding sites and is also mediated by multivalent interactions involving the amino and carboxy-terminal TDP-43 domains. The physiological relevance of RNA-driven TDP-43 condensation is supported by similar observations in mammalian cellular lysate. Importantly, we find that TDP-43-RNA association maintains liquid-like properties of the condensates, which are disrupted in the presence of ALS-linked TDP-43 mutations. Altogether, RNA binding plays a central role in modulating TDP-43 condensation while maintaining protein solubility, and defects in this RNA-mediated activity may underpin TDP-43-associated pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grese</LastName><ForeName>Zachary R</ForeName><Initials>ZR</Initials><AffiliationInfo><Affiliation>Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastos</LastName><ForeName>Alliny Cs</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-0675-7250</Identifier><AffiliationInfo><Affiliation>Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mamede</LastName><ForeName>Lohany D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayala</LastName><ForeName>Yuna M</ForeName><Initials>YM</Initials><Identifier Source="ORCID">0000-0003-4688-6583</Identifier><AffiliationInfo><Affiliation>Edward Doisy Department of Biochemistry and Molecular Biology, Saint Louis University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS078398</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS114289</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS105806</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">liquid-liquid phase separation</Keyword><Keyword MajorTopicYN="N">ribonucleoprotein (RNP) granules</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>17</Day><Hour>8</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34787357</ArticleId><ArticleId IdType="pmc">PMC8647020</ArticleId><ArticleId IdType="doi">10.15252/embr.202153632</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Afroz T, Hock E&#x2010;M, Ernst P, Foglieni C, Jambeau M, Gilhespy LAB, Laferriere F, Maniecka Z, Pl&#xfc;ckthun A, Mittl P et&#x2009;al (2017) Functional and dynamic polymerization of the ALS&#x2010;linked protein TDP&#x2010;43 antagonizes its pathologic aggregation. Nat Commun 8: 45</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N, Smith R, Carrasco M, Williams L, Winborn C, Han S, Kiskinis E, Winborn B, Freibaum B, Kanagaraj A et&#x2009;al (2014) Axonal transport of TDP&#x2010;43 mRNA granules is impaired by ALS&#x2010;causing mutations. Neuron 81: 536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et&#x2009;al (2006) TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avenda&#xf1;o&#x2010;V&#xe1;zquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E et&#x2009;al (2011) TDP&#x2010;43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277&#x2013;288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Misteli T, Baralle FE (2008) TDP&#x2010;43 regulates retinoblastoma protein phosphorylation through the repression of cyclin&#x2010;dependent kinase 6 expression. Proc Natl Acad Sci USA 105: 3785&#x2013;3789</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2268791</ArticleId><ArticleId IdType="pubmed">18305152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Pagani F, Baralle FE (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett 580: 1339&#x2013;1344</Citation><ArticleIdList><ArticleId IdType="pubmed">16458894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Pantano S, D'Ambrogio A, Buratti E, Brindisi A, Marchetti C, Romano M, Baralle FE (2005) Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348: 575&#x2013;588</Citation><ArticleIdList><ArticleId IdType="pubmed">15826655</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumer D, Parkinson N, Talbot K (2009) TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation. J Neurol Neurosurg Psychiatry 80: 1283&#x2013;1285</Citation><ArticleIdList><ArticleId IdType="pubmed">19864663</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, Eckmann CR, Courson DS, Rybarska A, Hoege C, Gharakhani J, Julicher F, Hyman AA (2009) Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 324: 1729&#x2013;1732</Citation><ArticleIdList><ArticleId IdType="pubmed">19460965</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP&#x2010;43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276: 36337&#x2013;36343</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2010) The multiple roles of TDP&#x2010;43 in pre&#x2010;mRNA processing and gene expression regulation. RNA Biol 7: 420&#x2013;429</Citation><ArticleIdList><ArticleId IdType="pubmed">20639693</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Brindisi A, Pagani F, Baralle FE (2004) Nuclear factor TDP&#x2010;43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74: 1322&#x2013;1325</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182100</ArticleId><ArticleId IdType="pubmed">15195661</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H&#x2010;J, Topp SD, Hui HS, Zacco E, Katarya M, McLoughlin C, King A, Smith BN, Troakes C, Pastore A et&#x2009;al (2019) RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP&#x2010;43 proteinopathy. Brain 142: 3753&#x2013;3770</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, Mutani R, Brunetti M, Ossola I, Marrosu MG et&#x2009;al (2011) Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol 68: 594&#x2013;598</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3513278</ArticleId><ArticleId IdType="pubmed">21220647</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Dignon GL, Zerze GH, Schmidt HB, D'Ordine AM, Kim YC, Rohatgi R, Ayala YM, Mittal J, Fawzi NL (2020) TDP&#x2010;43 alpha&#x2010;helical structure tunes liquid&#x2010;liquid phase separation and function. Proc Natl Acad Sci USA 117: 5883&#x2013;5894</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL (2016) ALS mutations disrupt phase separation mediated by &#x3b1;&#x2010;helical structure in the TDP&#x2010;43 low&#x2010;complexity C&#x2010;terminal domain. Structure 24: 1537&#x2013;1549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G (2012) TDP&#x2010;43 aggregation in neurodegeneration: Are stress granules the key? Brain Res 1462: 16&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Feric M, Vaidya N, Harmon TS, Mitrea DM, Zhu L, Richardson TM, Kriwacki RW, Pappu RV, Brangwynne CP (2016) Coexisting liquid phases underlie nucleolar subcompartments. Cell 165: 1686&#x2013;1697</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127388</ArticleId><ArticleId IdType="pubmed">27212236</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, Li X, Malik AM, Martinez J, Beg AA, Barmada SJ (2019) An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43&#x2010;dependent neurodegeneration. Cell Rep 27: 1133&#x2013;1150</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Messing J, Yang P, Kim HJ, Taylor JP (2021) High&#x2010;fidelity reconstitution of stress granules and nucleoli in mammalian cellular lysate. J Cell Biol 220: e202009079</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845923</ArticleId><ArticleId IdType="pubmed">33502444</ArticleId></ArticleIdList></Reference><Reference><Citation>French RL, Grese ZR, Aligireddy H, Dhavale DD, Reeb AN, Kedia N, Kotzbauer PT, Bieschke J, Ayala YM (2019) Detection of TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) oligomers as initial intermediate species during aggregate formation. J Biol Chem 294: 6696&#x2013;6709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y, Ikeda M, Yanagisawa T, Senoo Y, Okamoto K (2011) Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation. Neurology 77: 1427&#x2013;1431</Citation><ArticleIdList><ArticleId IdType="pubmed">21956716</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Jove Navarro M, Kashida S, Chouaib R, Souquere S, Pierron G, Weil D, Gueroui Z (2019) RNA is a critical element for the sizing and the composition of phase&#x2010;separated RNA&#x2010;protein condensates. Nat Commun 10: 3230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642089</ArticleId><ArticleId IdType="pubmed">31324804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset&#x2010;Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, Cleveland DW (2019) Cytoplasmic TDP&#x2010;43 de&#x2010;mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP&#x2010;43, and cell death. Neuron 102: 339&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL III, Bigio EH, Caselli R et&#x2009;al (2008) TDP&#x2010;43 A315T mutation in familial motor neuron disease. Ann Neurol 63: 535&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaur EL (2017) Amyotrophic lateral sclerosis&#x2010;linked mutations increase the viscosity of liquid&#x2010;like TDP&#x2010;43 RNP granules in neurons. Proc Natl Acad Sci USA 114: E2466&#x2013;E2475</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallegger M, Chakrabarti AM, Lee FCY, Lee BL, Amalietti AG, Odeh HM, Copley KE, Rubien JD, Portz B, Kuret K et&#x2009;al (2021) TDP&#x2010;43 condensation properties specify its RNA&#x2010;binding and regulatory repertoire. Cell 184: 4680&#x2013;4696</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445024</ArticleId><ArticleId IdType="pubmed">34380047</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumikawa K, Nobe Y, Ishikawa H, Yamauchi Y, Taoka M, Sato K, Nakayama H, Simpson RJ, Isobe T, Takahashi N (2019) TDP&#x2010;43 regulates site&#x2010;specific 2'&#x2010;O&#x2010;methylation of U1 and U2 snRNAs via controlling the Cajal body localization of a subset of C/D scaRNAs. Nucleic Acids Res 47: 2487&#x2013;2505</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6412121</ArticleId><ArticleId IdType="pubmed">30759234</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP&#x2010;43 is intrinsically aggregation&#x2010;prone, and amyotrophic lateral sclerosis&#x2010;linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329&#x2013;20339</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A, Shibasaki A, Takeda K, Suno R, Kinjo M (2018) Analysis of the substrate recognition state of TDP&#x2010;43 to single&#x2010;stranded DNA using fluorescence correlation spectroscopy. Biochem Biophys Rep 14: 58&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986658</ArticleId><ArticleId IdType="pubmed">29872735</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A, Sugai A, Kato T, Ishihara T, Shiga A, Toyoshima Y, Koyama M, Konno T, Hirokawa S, Yokoseki A et&#x2009;al (2016) Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP&#x2010;43. Nucleic Acids Res 44: 5820&#x2013;5836</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937342</ArticleId><ArticleId IdType="pubmed">27257061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS (2009) Structural insights into TDP&#x2010;43 in nucleic&#x2010;acid binding and domain interactions. Nucleic Acids Res 37: 1799&#x2013;1808</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Banjade S, Cheng H&#x2010;C, Kim S, Chen B, Guo L, Llaguno M, Hollingsworth JV, King DS, Banani SF et&#x2009;al (2012) Phase transitions in the assembly of multivalent signalling proteins. Nature 483: 336&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3343696</ArticleId><ArticleId IdType="pubmed">22398450</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Reeb AN, Lin B, Subramanian P, Fey EE, Knoverek CR, French RL, Bigio EH, Ayala YM (2017) Heat shock&#x2010;induced phosphorylation of TAR DNA&#x2010;binding protein 43 (TDP&#x2010;43) by MAPK/ERK kinase regulates TDP&#x2010;43 function. J Biol Chem 292: 5089&#x2013;5100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5377819</ArticleId><ArticleId IdType="pubmed">28167528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Protter DS, Rosen MK, Parker R (2015) Formation and maturation of phase&#x2010;separated liquid droplets by RNA&#x2010;binding proteins. Mol Cell 60: 208&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC (2015) TDP&#x2010;43 repression of nonconserved cryptic exons is compromised in ALS&#x2010;FTD. Science 349: 650&#x2013;655</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, Baralle FE, Damberger FF, Allain FH (2013) Molecular basis of UG&#x2010;rich RNA recognition by the human splicing factor TDP&#x2010;43. Nat Struct Mol Biol 20: 1443&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A et&#x2009;al (2017) TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron 95: 808&#x2013;816</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, Wang J, Papadopoulos DK, Richter D, Pozniakovsky A, Poser I, Bickle M, Rizk S, Guill&#xe9;n&#x2010;Boixet J, Franzmann TM et&#x2009;al (2018) RNA buffers the phase separation behavior of prion&#x2010;like RNA binding proteins. Science 360: 918&#x2013;921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis&#x2010;Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ et&#x2009;al (2019) RNA binding antagonizes neurotoxic phase transitions of TDP&#x2010;43. Neuron 102: 321&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L, Mojsilovic&#x2010;Petrovic J, Tran V, Kalb RG, Shorter J, Bonini NM (2018) Poly(ADP&#x2010;Ribose) prevents pathological phase separation of TDP&#x2010;43 by promoting liquid demixing and stress granule localization. Mol Cell 71: 703&#x2013;717</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, Perl DP, Hedley&#x2010;Whyte ET, Price B, Sullivan C et&#x2009;al (2010) TDP&#x2010;43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 69: 918&#x2013;929</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Ze&#x2019;ev, L&#xf3;pez&#x2010;Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW et&#x2009;al (2019) Premature polyadenylation&#x2010;mediated loss of stathmin&#x2010;2 is a hallmark of TDP&#x2010;43&#x2010;dependent neurodegeneration. Nat Neurosci 22: 180&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Modic M, Grosch M, Rot G, Schirge S, Lepko T, Yamazaki T, Lee FCY, Rusha E, Shaposhnikov D, Palo M et&#x2009;al (2019) Cross&#x2010;Regulation between TDP&#x2010;43 and Paraspeckles Promotes Pluripotency&#x2010;Differentiation Transition. Mol Cell 74: 951&#x2013;965</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6561722</ArticleId><ArticleId IdType="pubmed">31047794</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163: 123&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M, Romano V, Pantoja&#x2010;Uceda D, Stuani C, Baralle FE, Buratti E, Laurents DV (2017) Point mutations in the N&#x2010;terminal domain of transactive response DNA&#x2010;binding protein 43 kDa (TDP&#x2010;43) compromise its stability, dimerization, and functions. J Biol Chem 292: 11992&#x2013;12006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512090</ArticleId><ArticleId IdType="pubmed">28566288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C et&#x2009;al (2019) Limbic&#x2010;predominant age&#x2010;related TDP&#x2010;43 encephalopathy (LATE): consensus working group report. Brain 142: 1503&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et&#x2009;al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee H, Jawerth L, Maharana S, Jahnel M, Hein M, Stoynov S, Mahamid J, Saha S, Franzmann T et&#x2009;al (2015) A liquid&#x2010;to&#x2010;solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162: 1066&#x2013;1077</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling S&#x2010;C, Sun E, Wancewicz E, Mazur C et&#x2009;al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rengifo&#x2010;Gonzalez JC, El Hage K, Cl&#xe9;ment M&#x2010;J, Steiner E, Joshi V, Craveur P, Durand D, Pastr&#xe9; D, Bouhss A (2021) The cooperative binding of TDP&#x2010;43 to GU&#x2010;rich RNA repeats antagonizes TDP&#x2010;43 aggregation. eLife 10.7554/elife.67605</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.67605</ArticleId><ArticleId IdType="pmc">PMC8523171</ArticleId><ArticleId IdType="pubmed">34490845</ArticleId></ArticleIdList></Reference><Reference><Citation>Rot G, Wang Z, Huppertz I, Modic M, Lence T, Hallegger M, Haberman N, Curk T, von Mering C, Ule J (2017) High&#x2010;resolution RNA maps suggest common principles of splicing and polyadenylation regulation by TDP&#x2010;43. Cell Rep 19: 1056&#x2013;1067</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437728</ArticleId><ArticleId IdType="pubmed">28467899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang Y&#x2010;J, Baker M, Gass JM, Finch NA, Xu Y&#x2010;F, Stewart H, Kelley BJ, Kuntz K, Crook RJP et&#x2009;al (2008) Novel mutations in TARDBP (TDP&#x2010;43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 4: e1000193</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB, Rohatgi R (2016) In vivo formation of vacuolated multi&#x2010;phase compartments lacking membranes. Cell Rep 16: 1228&#x2013;1236</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972689</ArticleId><ArticleId IdType="pubmed">27452472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et&#x2009;al (2008) TDP&#x2010;43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaoka A, Arai M, Itokawa M, Arai T, Hasegawa M, Tsuchiya K, Takuma H, Tsuji H, Ishii A, Watanabe M et&#x2009;al (2010) TDP&#x2010;43 M337V mutation in familial amyotrophic lateral sclerosis in Japan. Intern Med 49: 331&#x2013;334</Citation><ArticleIdList><ArticleId IdType="pubmed">20154440</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, K&#xf6;nig J, Hortob&#xe1;gyi T, Nishimura AL, &#x17d;upunski V et&#x2009;al (2011) Characterizing the RNA targets and position&#x2010;dependent splicing regulation by TDP&#x2010;43. Nat Neurosci 14: 452&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan&#x2010;Johns M, Bengoechea R, Bell S, Shao J, Diamond MI, True HL, Weihl CC, Baloh RH (2014) Prion&#x2010;like nuclear aggregation of TDP&#x2010;43 during heat shock is regulated by HSP40/70 chaperones. Hum Mol Genet 23: 157&#x2013;170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, Nourse A, Ramirez Montero D, Ryan VH, Rohatgi R et&#x2009;al (2018) A single N&#x2010;terminal phosphomimic disrupts TDP&#x2010;43 polymerization, phase separation, and RNA splicing. EMBO J 37: e97452</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y&#x2010;T, Kuo P&#x2010;H, Chiang C&#x2010;H, Liang J&#x2010;R, Chen Y&#x2010;R, Wang S, Shen JCK, Yuan HS (2013) The truncated C&#x2010;terminal RNA recognition motif of TDP&#x2010;43 protein plays a key role in forming proteinaceous aggregates. J Biol Chem 288: 9049&#x2013;9057</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610977</ArticleId><ArticleId IdType="pubmed">23372158</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Pestronk A, Kimonis VE (2009) Valosin&#x2010;containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto&#x2010;temporal dementia. Neuromuscul Disord 19: 308&#x2013;315</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859037</ArticleId><ArticleId IdType="pubmed">19380227</ArticleId></ArticleIdList></Reference><Reference><Citation>West JA, Mito M, Kurosaka S, Takumi T, Tanegashima C, Chujo T, Yanaka K, Kingston RE, Hirose T, Bond C et&#x2009;al (2016) Structural, super&#x2010;resolution microscopy analysis of paraspeckle nuclear body organization. J Cell Biol 214: 817&#x2013;830</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5037409</ArticleId><ArticleId IdType="pubmed">27646274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wippich F, Bodenmiller B, Trajkovska MG, Wanka S, Aebersold R, Pelkmans L (2013) Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 152: 791&#x2013;805</Citation><ArticleIdList><ArticleId IdType="pubmed">23415227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood M, Quinet A, Lin YL, Davis AA, Pasero P, Ayala YM, Vindigni A (2020) TDP&#x2010;43 dysfunction results in R&#x2010;loop accumulation and DNA replication defects. J Cell Sci 133: jcs244129</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648616</ArticleId><ArticleId IdType="pubmed">32989039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Elbaum&#x2010;Garfinkle S, Langdon EM, Taylor N, Occhipinti P, Bridges AA, Brangwynne CP, Gladfelter AS (2015) RNA controls PolyQ protein phase transitions. Mol Cell 60: 220&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221516</ArticleId><ArticleId IdType="pubmed">26474065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>